[Long-Term Survival in Esophagogastric Junction Cancer with Multiple Lymph Node Metastasis Through Pre-and-Post Operative Chemotherapy]

Gan To Kagaku Ryoho. 2024 Dec;51(12):1259-1262.
[Article in Japanese]

Abstract

A 62-year-old man was diagnosed with Stage Ⅲ signet ring cell carcinoma of the lower thoracic esophagus. The patient underwent 2 courses of neoadjuvant cisplatin and 5-fluorouracil(SP therapy), demonstrating stable efficacy. Subsequently, the patient underwent subtotal esophagectomy with thoracoabdominal 2-field lymphadenectomy via right thoracotomy, followed by esophageal reconstruction using a gastric tube through a retrosternal route. Pathological examination revealed a signet ring cell carcinoma of the esophagogastric junction(pT3, pN2, sM0, and fStage Ⅲ). Postoperatively, the patient received chemotherapy with S-1 for 2 years owing to multiple lymph node metastases. Remarkably, the patient remained free of recurrence 6 years after surgery. We encountered a case of long-term survival in esophagogastric junction cancer with multiple lymph node metastases, typically associated with poor prognosis, following pre- and postoperative chemotherapy and radical surgery.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols* / therapeutic use
  • Carcinoma, Signet Ring Cell / drug therapy
  • Carcinoma, Signet Ring Cell / pathology
  • Carcinoma, Signet Ring Cell / secondary
  • Carcinoma, Signet Ring Cell / surgery
  • Cisplatin / administration & dosage
  • Drug Combinations*
  • Esophageal Neoplasms* / drug therapy
  • Esophageal Neoplasms* / pathology
  • Esophageal Neoplasms* / surgery
  • Esophagectomy*
  • Esophagogastric Junction* / pathology
  • Esophagogastric Junction* / surgery
  • Fluorouracil / administration & dosage
  • Fluorouracil / therapeutic use
  • Humans
  • Lymph Node Excision
  • Lymphatic Metastasis*
  • Male
  • Middle Aged
  • Neoadjuvant Therapy
  • Oxonic Acid / administration & dosage
  • Oxonic Acid / therapeutic use
  • Tegafur / administration & dosage
  • Tegafur / therapeutic use
  • Time Factors

Substances

  • Drug Combinations
  • S 1 (combination)
  • Oxonic Acid
  • Tegafur
  • Cisplatin
  • Fluorouracil